Literature DB >> 33383126

Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1.

Jin Hee Park1, Hee Yeon Kim2, Anbok Lee2, Young Kyeong Seo3, Il-Hwan Kim4, Eun-Tae Park5, Mi Seon Kang6, Sung Jae Park3, SaeGwang Park7.   

Abstract

PURPOSE: The establishment of a preclinical model of the abscopal effect on hepatocellular carcinoma (HCC) and evaluation of whether the hypofractionated radiation therapy (RT) multitumor Hepa1-6 mouse HCC model could be used to suppress nonradiated tumor mass was performed in this study. METHODS AND MATERIALS: Hepa1-6 mouse liver cancer cell lines were used to form tumors. Immunogenicity was analyzed using ELISpot and immune cell labeled antibody. Interferon (IFN) β expression was confirmed through polymerase chain reaction.
RESULTS: After investigation, the intratumoral transcription of type Ⅰ IFN increased by 2-fold. The antitumor immune response to Hepa 1-6 cells induced by radiation was increased. Moreover, the influx of activated CD8+ T cells was increased in nonirradiated tumors. The number of dendritic cells and activation status were evaluated by flow cytometry on the second day after irradiation. Flow cytometry revealed a significantly increased dendritic cell population expressing the CD11c molecule in tumor-draining lymph nodes. Furthermore, because irradiation leads to adaptation of immune resistance of tumor cells against RT, we sought to elucidate a potent tool to overcome the resistance and confirm the ability of PD-L1 antibody to survive late RT resistance.
CONCLUSIONS: The immunologic mechanism of the abscopal effect was revealed and the application of PD-L1 inhibitor successfully performed as a breakthrough in late RT resistance in the Hepa1-6 tumor model.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33383126     DOI: 10.1016/j.ijrobp.2020.12.031

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Dynamic proteomic change of tumor and immune organs in an immune-competent hepatocellular carcinoma mouse model.

Authors:  Jiaqi Jiao; Linlin Ji; Xianju Li; Zhan Gao; Guangshun Wang; Jun Qin; Yini Wang; Yi Wang
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

2.  Radiosensitization effect by HDAC inhibition improves NKG2D-dependent natural killer cytotoxicity in hepatocellular carcinoma.

Authors:  Yu-Fan Liu; Yun Chiang; Feng-Ming Hsu; Chiao-Ling Tsai; Jason Chia-Hsien Cheng
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.